期刊
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
卷 103, 期 10, 页码 1062-1064出版社
OXFORD UNIV PRESS
DOI: 10.1016/j.trstmh.2009.01.026
关键词
Schistosomiasis; Artesunate; Sulfadoxine/pyrimethamine; Praziquantel; Treatment outcome; Sudan
资金
- Kenana Engineering and Technical Services, Khartoum, Sudan
The efficacy and safety of oral artesunate+sulfadoxine/pyrimethamine (AS+SP) (4 mg/kg AS for 3 consecutive days + 25 mg sulfadoxine on Day 0) in the treatment of Schistosoma mansoni infections were compared with those of praziquantel (PZQ) (40 mg/kg) among infected schoolchildren (46 in each study arm) in eastern Sudan. The cure rate at 28 days was 58.6% in the AS+SP group and 100% in the PZQ group (P < 0.001). While drug-related adverse effects (headache, dizziness, nausea and diarrhoea) were not significantly different between the two groups, significantly more children suffered abdominal pain in the PZQ group than in the AS+SP group (P = 0.001). Thus, AS+SP has poor efficacy in the treatment of S. mansoni compared with PZQ. (c) 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据